JPMorgan Chase & Co. Forecasts Strong Price Appreciation for Quest Diagnostics (NYSE:DGX) Stock
Quest Diagnostics (NYSE:DGX – Free Report) had its price target boosted by JPMorgan Chase & Co. from $180.00 to $190.00 in a research note released on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other research firms have also recently issued reports on DGX. UBS […]
Quest Diagnostics (NYSE:DGX – Free Report) had its price target boosted by JPMorgan Chase & Co. from $180.00 to $190.00 in a research note released on Tuesday,Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the medical research company’s stock. Several other research firms have also recently issued reports on DGX. UBS […]
